|
|
||||||||
RESEARCH REPORT |
Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, Québec City, Québec, Canada G1K 7P4
* corresponding author, Daniel.Grenier{at}greb.ulaval.ca
| ABSTRACT |
|---|
|
|
|---|
), and Regulated on Activation Normal T-cell Expressed and Secreted (RANTES) production by macrophages treated with the cranberry fraction prior to stimulation by LPS was evaluated by ELISA. Our results clearly indicate that the cranberry fraction was a potent inhibitor of the pro-inflammatory cytokine and chemokine responses induced by LPS. This suggests that cranberry constituents may offer perspectives for the development of a new therapeutic approach to the prevention and treatment of periodontitis.
KEY WORDS: cranberry periodontopathogen macrophage anti-inflammatory cytokine
| INTRODUCTION |
|---|
|
|
|---|
) by host cells following stimulation by periodontopathogensmodulates periodontal tissue destruction (Okada and Murakami, 1998). Active compounds endowed with a capacity to modulate the host inflammatory response are now receiving considerable attention, since they may be potential new therapeutic agents for the treatment of periodontal diseases (Paquette and Williams, 2000). The cranberry is a native North American fruit with various beneficial properties for human health, such as the inhibition of human cancer cell line proliferation (Ferguson et al., 2004; Seeram et al., 2004) and the prevention of adherence of urinary tract infectious agents (Raz et al., 2004). In the area of dental research, it has been reported that a high-molecular-weight fraction prepared from cranberry juice inhibits the co-aggregation of many oral bacteria (Weiss et al., 1998) and affects dental biofilm formation (Steinberg et al., 2004; Yamanaka et al., 2004). In addition, this cranberry fraction reduces mutans streptococci levels in saliva, inhibits in vitro adhesion of Streptococcus sobrinus to hydroxyapatite (Weiss et al., 2004), and promotes S. sobrinus desorption from artificial biofilms (Steinberg et al., 2005).
In this study, we hypothesized that the cranberry may have a beneficial effect in periodontitis by exerting an anti-inflammatory effect. Therefore, we investigated the effect of a high-molecular-weight cranberry fraction prepared from juice concentrate on the production by macrophages of pro-inflammatory cytokines and chemokines associated with periodontitis. More specifically, the cytokine and chemokine responses of macrophages were induced by LPS prepared from Escherichia coli and from the major periodontopathogens: Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum subsp. nucleatum, P. gingivalis, T. denticola, and T. forsythia.
| MATERIALS & METHODS |
|---|
|
|
|---|
LPS Preparation
A. actinomycetemcomitans ATCC 29522, F. nucleatum subsp. nucleatum ATCC 25586, P. gingivalis ATCC 33277, T. denticola ATCC 35405, and T. forsythia ATCC 43037 were grown in their appropriate culture media (Grenier, 1996). LPS were isolated from these bacterial strains, as previously reported (Darveau and Hancock, 1983). This method is based on protein digestion of a whole-cell extract by proteinase K and successive solubilization and precipitation steps. The LPS preparations were freeze-dried and kept at 20°C. The amount of contaminating protein was evaluated with the use of a protein assay kit (Bio-Rad Laboratories, Mississauga, ON, Canada), with bovine serum albumin as a control, and was less than 0.001% in all LPS preparations. T. denticola possesses a lipooligosaccharide (although it will be called LPS in the present paper) that has properties rather distinct from those of the classic LPS of the Bacteroides group (Schultz et al., 1998). A standard LPS preparation from E. coli O55:B5 (Sigma Chemical Co.) was also used.
Monocyte and Macrophage Cultures
U937 cells (ATCC CRL-1593.2), a monoblastic leukemia cell line, were cultivated at 37°C in a 5% CO2 atmosphere in RPMI-1640 medium (HyClone Laboratories, Logan, UT, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (RPMI-FBS) and 100 µg/mL of penicillin-streptomycin. Monocytes (2 x 105 cells/mL) were incubated in RPMI-FBS containing 10 ng/mL of phorbol myristic acid (PMA; Sigma) for 48 hrs to induce differentiation into adherent macrophage-like cells, as previously reported (Rovera et al., 1979). Following the PMA treatment, the medium was replaced with fresh medium, and the differentiated cells were incubated for an additional 24 hrs prior to use. Adherent macrophages were suspended in RPMI-FBS and centrifuged at 200 x g for 8 min. They were washed and suspended in RPMI with 1% heat-inactivated FBS at a density of 1 x 106 cells/mL and seeded in a six-well plate (2 x 106 cells/well in 2 mL) at 37°C in a 5% CO2 atmosphere.
Treatment of Macrophages
The macrophages were treated with increasing concentrations of fraction 1, fraction 2, and EGCG, ranging from 10 to 50 µg/mL, and incubated at 37°C in 5% CO2 for 2 hrs before stimulation with LPS at a final concentration of 1 µg/mL. After a 24-hour incubation (37°C in 5% CO2), the culture medium supernatants were collected and stored at 20°C until used. Cells incubated in culture medium with or without cranberry fraction or EGCG, but not stimulated with LPS, were used as controls.
Cell Viability
Macrophage viability was evaluated by 0.2% Trypan Blue staining. Cell viability of macrophages was also evaluated by a MTT (3-[4,5-diethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test, according to the manufacturers protocol (Roche Diagnostics, Mannheim, Germany).
Determination of Cytokine Production
We used commercial enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA) to quantify IL-1ß, IL-6, IL-8, TNF-
, and RANTES concentrations in the cell-free culture supernatants, according to the manufacturers protocols. The absorbance at 450 nm was read in a microplate reader with the wavelength correction set at 550 nm.
Statistical Analyses
We performed two-way analyses of variance to compare the means of the different conditions. Differences were deemed significant at the 0.05 level (P value). Protected Fisher least-significant differences were used for pairwise comparisons.
| RESULTS |
|---|
|
|
|---|
94% of the untreated controls in all experiments (data not shown).
For IL-1ß, TNF-
, and IL-6, the interaction between the two factors LPS and cranberry was significant (P < 0.05), and the results of pairwise comparisons were used. The TNF-
and IL-6 responses of the macrophages stimulated by LPS from A. actinomycetemcomitans were significantly reduced by the treatments with fraction 1 (25 and 50 µg/mL) and EGCG (10 µg/mL) (Figs. 1A, 1B
). This effect was not observed when the macrophages were treated with fraction 2. Among the other LPS tested, the LPS from F. nucleatum subsp. nucleatum and E. coli induced a TNF-
response, whereas an IL-6 response was induced only by the LPS of F. nucleatum subsp. nucleatum (Table
). Fraction 1 at a final concentration of 50 µg/mL inhibited the TNF-
and IL-6 responses of macrophages induced by the LPS of F. nucleatum subsp. nucleatum, as well as the TNF-
response induced by the LPS of E. coli.
|
|
Effects of Cranberry Fractions on LPS-induced Chemokine Production
For IL-8, the interaction between LPS and the cranberry fractions was not significant, and the effects of cranberry fraction 1 were analyzed without discrimination of LPS source. LPS of A. actinomycetemcomitans induced a higher IL-8 response than did the other LPS tested (P < 0.05). Fraction 1 (50 µg/mL) significantly reduced the IL-8 response of macrophages stimulated with LPS (Fig. 2A
, Table
). Fraction 2 and EGCG had no effect on IL-8 production by LPS-stimulated macrophages.
|
| DISCUSSION |
|---|
|
|
|---|
Cytokines, more particularly IL-1ß, are potential markers of the progression and severity of periodontitis as well as indicators of an appropriate response to treatment (Hou et al., 1995). It has been reported that cytokine synthesis inhibitors can reduce bone resorption in experimental periodontitis in rats (Lima et al., 2004). Moreover, local inhibition of both IL-1 and TNF production in periodontal tissues significantly inhibits the inflammatory response and bone loss in ligature-induced periodontitis in monkeys (Assuma et al., 1998). This suggests that local inhibition of cytokines may be a successful approach for inhibiting bone resorption in periodontitis. In this study, we showed that treating macrophages with the non-dialyzable material of cranberry juice can inhibit LPS-induced IL-1ß, TNF-
, and IL-6 production and may thus contribute to reducing the impact of cytokine-mediated host destructive processes in periodontitis.
IL-8 and RANTES are potent chemokines that direct the migration of neutrophils, eosinophils, monocytes, and TH1 cells to sites of infection (Luster, 1998). Stimulation of chemokine production by periodontopathogens favors the accumulation of leukocytes during active inflammation, which contributes to periodontal tissue destruction. Interestingly, periodontal therapy reduces cell numbers in the infiltrate and the levels of IL-8 and RANTES, suggesting a relationship between these chemokines and periodontal status (Gamonal et al., 2001). The non-dialyzable material of cranberry juice reduced LPS-induced IL-8 and RANTES production by macrophages. In the context of the development of novel therapeutic strategies targeting the control of periodontal inflammatory reactions, these results suggest that this cranberry fraction may help reduce the influx of inflammatory cells at disease sites.
The lyophilized cranberry juice did not show any capacity to inhibit LPS-induced cytokine production by macrophages. This is likely related to the fact that active compounds were concentrated in the non-dialyzable material of cranberry juice. One such group of compounds that showed a 125-fold enrichment was the proanthocyanidins (data not shown). EGCG, the green tea polyphenol used as a positive control, also showed anti-inflammatory activity. This is in agreement with the previously reported capacity of EGCG to inhibit LPS-induced TNF-
production by mouse macrophages (Yang et al., 1998). Previous studies have revealed that some plant flavonoids may inhibit the expression of inflammation-related proteins/enzymes by suppressing activation of transcription factors such as nuclear transcription factor-
B and activator protein-1 (Kim et al., 2004). Future studies will investigate the cellular mechanisms by which cranberry constituents modulate cytokine expression.
Therapeutic agents that modulate host inflammatory mediators have shown promise for managing adult periodontitis and may be highly useful for individuals with a substantially increased risk for periodontitis (Kornman, 1999). In addition to the previously recognized inhibitory effect of the cranberry non-dialyzable material fraction on the aggregation of oral bacteria and dental biofilm formation (Weiss et al., 1998; Steinberg et al., 2004), we showed that this fraction was a potent inhibitor of the pro-inflammatory cytokine and chemokine responses induced by periodontopathogens and E. coli. This provides promising perspectives for the development of novel host-modulating therapies for adjunctive treatments of periodontitis or other inflammatory diseases by use of the high-molecular-weight constituents from cranberries.
| ACKNOWLEDGMENTS |
|---|
Received April 25, 2005; Last revision October 14, 2005; Accepted October 26, 2005
| REFERENCES |
|---|
|
|
|---|
Darveau RP, Hancock RE (1983). Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155:831838.
Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ (2004). A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134:15291535.
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001). Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36:194203.[ISI][Medline]
Grenier D (1996). Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 142(Pt 4):955961.[Abstract]
Haffajee AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5:78111.
Henderson B, Poole S, Wilson M (1996). Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60:316341.
Hou LT, Liu CM, Rossomando EF (1995). Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 22:162167.[ISI][Medline]
Kim HP, Son KH, Chang HW, Kang SS (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96:229245.[ISI][Medline]
Kornman KS (1999). Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 28:520526.[ISI][Medline]
Kornman KS, Page RC, Tonetti MS (1997). The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14:3353.
Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA (2004). Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 75:162168.[ISI][Medline]
Luster AD (1998). Chemokineschemotactic cytokines that mediate inflammation. N Engl J Med 338:436445.
Okada H, Murakami S (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9:248266.
Paquette DW, Williams RC (2000). Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 24:239252.
Raz R, Chazan B, Dan M (2004). Cranberry juice and urinary tract infection. Clin Infect Dis 38:14131419.[ISI][Medline]
Rovera G, Santoli D, Damsky C (1979). Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:27792783.
Schultz CP, Wolf V, Lange R, Mertens E, Wecke J, Naumann D, et al. (1998). Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola. Functioning permeation barrier without lipopolysaccharides. J Biol Chem 273:1566115666.
Seeram NP, Adams LS, Hardy ML, Heber D (2004). Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52:25122517.[ISI][Medline]
Steinberg D, Feldman M, Ofek I, Weiss EI (2004). Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm. J Antimicrob Chemother 54:8689.
Steinberg D, Feldman M, Ofek I, Weiss EI (2005). Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Antimicrob Agents 25:247251.[ISI][Medline]
Weiss EI, Lev-Dor R, Kashamn Y, Goldhar J, Sharon N, Ofek I (1998). Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. J Am Dent Assoc 129:17191723. [Published erratum appears in J Am Dent Assoc 130(1):36 and 130(3):332, 1999.]
Weiss EI, Kozlovsky A, Steinberg D, Lev-Dor R, Bar Ness Greenstein R, Feldman M, et al. (2004). A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 232:8992.[ISI][Medline]
Yamanaka A, Kimizuka R, Kato T, Okuda K (2004). Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 19:150154.[ISI][Medline]
Yang F, de Villiers WJ, McClain CJ, Varilek GW (1998). Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128:23342340.
Zappa U, Reinking-Zappa M, Graf H, Espeland M (1991). Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 18:508515.[ISI][Medline]
This article has been cited by other articles:
![]() |
C. C. Neto Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies J. Nutr., January 1, 2007; 137(1): 186S - 193S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Labrecque, C. Bodet, F. Chandad, and D. Grenier Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis J. Antimicrob. Chemother., August 1, 2006; 58(2): 439 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bodet, M. Piche, F. Chandad, and D. Grenier Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry J. Antimicrob. Chemother., April 1, 2006; 57(4): 685 - 690. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |